CaliberCos Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CaliberCos Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.10M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $51.12M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $90.94M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $83.96M | Apr 16, 2024 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.20M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $20.90M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $20.60M | Mar 31, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($21.80M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($19.78M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($12.70M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $2.02M | Apr 16, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($12.07M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $555.0K | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($18.72M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($7.43M) | Apr 16, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $135.40M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $105.54M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $299.43M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $278.83M | Apr 16, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $109.17M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $94.28M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $233.41M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $201.65M | Apr 16, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.33M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($12.59M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.62M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($3.21M) | Apr 16, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($78.41M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($56.61M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($36.83M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($22.71M) | Apr 16, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.86M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.32M | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | $3.81M | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | $7.66M | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | $8.38M | Apr 16, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (7) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | (17) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (7) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | (17) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 15.18M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | 13.87M | Mar 31, 2025 |